Study of Adding Cetuximab to Chemotherapy for the Treatment of Advanced and/or Recurrent Cervical Cancer (MITO CERV 2)
Trial Number
NCT00997009 (ClinicalTrials.gov Identifier)Contact Person
Status
Completed
Disease Site
Cervical
Study of Adding Cetuximab to Chemotherapy for the Treatment of Advanced and/or Recurrent Cervical Cancer (MITO CERV 2)